Proacta

About Proacta

Proacta S.A. operates at the intersection of bioinformatics, artificial intelligence, and software development, primarily serving the healthcare sector. The company's business model is twofold. A significant portion of revenue is generated through its software house, which has been executing IT projects for global clients across various industries for over 15 years, completing over 100 projects. This division provides a stable income stream that is reinvested into the company's strategic focus: bioinformatics and medtech.

Since 2018, Proacta has concentrated on applying technology to solve challenges within the healthcare system. The company develops advanced services and proprietary products for the medical sector, leveraging AI and machine learning. Its core competencies include designing predictive models, technology consulting, data analysis of medical and genetic data, and creating dedicated software for clinical decision support. Proacta's team specializes in handling medical data from various systems like HIS, LIMS, and EHR, preparing it for analysis to extract valuable insights. This capability supports the development of personalized therapies and aims to increase diagnostic precision.

The firm has established strategic partnerships with key players in the medical and medtech industries, along with collaborations with hospitals and medical universities. Proacta offers several products, including a "Patient Portal" for health monitoring and data management, and the "Dbam o siebie Smart LAB" platform. In 2024, the company began generating its first revenue from these proprietary products. The company actively seeks to fund the development of its solutions through initiatives like the National Recovery Plan (NRP).